Nanostim, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nanostim.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Evaluation of a New Cardiac Pacemaker
Not Applicable
- Conditions
- Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) BlockNormal Sinus Rhythm With 2 or 3° AV or BBB BlockSinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Nanostim, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01700244
- Locations
- 🇨🇿
Na Homolce Hospital, Prague 5, Prague, Czech Republic
🇨🇿IKEM, Prague 4, Czech Republic
🇩🇪Kerckhoff Clinic, Bad Nauheim, Germany
News
No news found